Commentary

Video

Dr Levy on the Development and Clinical Use of ADCs in NSCLC

Benjamin P. Levy, MD, discusses the current clinical and developmental statuses of several ADCs for patients with non–small cell lung cancer.

Benjamin P. Levy, MD, clinical director, Medical Oncology, Johns Hopkins Sidney Kimmel Cancer Center at Sibley Memorial Hospital; and associate professor, oncology, Johns Hopkins University School of Medicine, discusses the current clinical and developmental statuses of several antibody-drug conjugates in non–small cell lung cancer.

Related Videos
Ignacio Garrido-Laguna, MD, PhD, MBA
Marwan G. Fakih, MD
Dr Alderuccio on Loncastuximab Tesirine With Rituximab in R/R Follicular Lymphoma
Dr Cascone on Evaluating Neoadjuvant Durvalumab-Based Regimens in Resectable NSCLC
Werutsky
Dr Sekkeres on the Association Between Smoking and Disease Progression in MDS
Lori Muffly, MD
Pooja Phull, MD
Eric Winer, MD
Jennifer Effie Amengual, MD